Frazier Life Sciences
18 portfolio companies · 4 on the map · $1.3B raised · 4 cities
Portfolio map
4 Frazier Life Sciences portfolio companies on the map.
Portfolio companies

Krystal Biotech
Pittsburgh
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Biotechnology$546MEst. 2016
Aspen Neuroscience
La Jolla
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Biotechnology Research$387MEst. 2018
Alentis Therapeutics
Allschwil
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Pharmaceutical Manufacturing$365.4MEst. 2019- A
Allakos
Redwood City
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Biotechnology ResearchPublic
More portfolio companies
14 more Frazier Life Sciences investments we track beyond the map.
Maze TherapeuticsSouth San Francisco · Post-IPO Equity
Angitia BiopharmaceuticalsWestlake Village · Series D
Enlaza TherapeuticsLa Jolla · Series A
GondolaBioPalo Alto · Venture
Soleno TherapeuticsRedwood City · Post-IPO Equity
Carmot TherapeuticsBerkeley · Series E
Lassen TherapeuticsSan Diego · Series B
Savara PharmaceuticalsAustin · Post-IPO Equity
Radionetics OncologyCalifornia City · Series A
Eledon PharmaceuticalsIrvine · Post-IPO Equity
Sidewinder TherapeuticsSan Diego · Series B
Halda TherapeuticsNew Haven · Series B
Callio TherapeuticsSeattle · Series A
iBioNewark · Post-IPO Equity
Portfolio map
4 Frazier Life Sciences portfolio companies on the map.